Dementia alzheimer's type and Glaucoma

Summary:

Glaucoma is found among people with Dementia alzheimer's type, especially for people who are male, 60+ old.

The study analyzes which people have Glaucoma with Dementia alzheimer's type. It is created by eHealthMe based on reports of 30 people who have Dementia alzheimer's type from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dementia alzheimer's type?

Dementia alzheimer's type (loss of mental ability with alzheimer's symptom) is found to be associated with 599 drugs and 749 conditions by eHealthMe. Check the latest studies of Dementia alzheimer's type.

What is Glaucoma?

Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 1,235 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Glaucoma.

On Jul, 07, 2026

30 people who have Dementia Alzheimer'S Type and Glaucoma are studied.

Would you have Glaucoma when you have Dementia alzheimer's type?

Gender of people who have Dementia Alzheimer'S Type and experienced Glaucoma *:

female: 46.43 %
male: 53.57 %

Age of people who have Dementia Alzheimer'S Type and experienced Glaucoma *:

Common co-existing conditions for these people *:

High Blood Pressure: 9 people, 30.00%
Depression: 5 people, 16.67%
High Blood Cholesterol: 5 people, 16.67%
Parkinson's Disease: 4 people, 13.33%
Osteoporosis (bones weak and more likely to break): 4 people, 13.33%
Urination - Excessive Volume: 3 people, 10.00%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 10.00%
Heart Disease: 2 people, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.67%
Constipation: 2 people, 6.67%

Common drugs taken by these people *:

Aricept: 10 people, 33.33%
Namenda: 6 people, 20.00%
Lasix: 4 people, 13.33%
Zocor: 3 people, 10.00%
Plavix: 3 people, 10.00%
Amlodipine Besylate: 3 people, 10.00%
Brinzolamide: 3 people, 10.00%
Exelon: 3 people, 10.00%
Fosamax: 3 people, 10.00%
Galantamine Hydrobromide: 3 people, 10.00%

Common symptoms for these people *:

Gait Disturbance: 6 people, 20.00%
Arrhythmias (irregular heartbeat): 4 people, 13.33%
Substance-Induced Psychotic Disorder: 4 people, 13.33%
Hallucination, Visual (seeing things that aren't there): 4 people, 13.33%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 4 people, 13.33%
Balance Disorder: 4 people, 13.33%
Hypotension (abnormally low blood pressure): 3 people, 10.00%
Exostosis (formation of new bone on the surface of a bone): 3 people, 10.00%
Pain In Jaw: 3 people, 10.00%
Hallucinations (sensations that appear real but are created by your mind): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Glaucoma?

- Check whether Glaucoma is associated with a drug or a condition

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

Related studies:

Treatments, associated drugs and conditions:

Dementia alzheimer's type (31,726 reports)
Glaucoma (61,926 reports)

All the drugs that are associated with Glaucoma:

Glaucoma (1,235 drugs)

All the conditions that are associated with Glaucoma:

Glaucoma (1,653 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Glaucoma and Dementia alzheimer's type, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.